MedPath

FLONASE - AEM-SUS NAS 50MCG/MD

FLONASE - AEM-SUS NAS 50MCG/MD

Discontinued
DIN Number

02213672

Drug Class

Human

Market Date

Mar 12, 1993

Company
HC

GlaxoSmithKline Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02213672
AIG Number0124685001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R01AD08 FLUTICASONE
Product Specifications
Dosage FormMetered-Dose Pump
Route of AdministrationNasal
AHFS Classification52:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLUTICASONE PROPIONATEActive
Strength: 50 MCG / ACT
Monograph: FLUTICASONE PROPIONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.